Ig Certified Pharmacist (IgCP) Credential – Practice Exam
2026
1. The PRIMARY role of an Ig Certified Pharmacist is to:
A. Dispense only intravenous medications
B. Ensure safe, effective, and compliant use of immunoglobulin therapy (Correct Answer)
C. Replace prescriber decision-making
D. Manage hospital staffing schedules
Rationale:
IgCP pharmacists specialize in optimizing immunoglobulin (Ig) therapy, ensuring
appropriateness, safety, and regulatory compliance.
2. Immunoglobulin therapy is MOST commonly indicated for:
A. Acute bacterial infections
B. Primary immunodeficiency disorders (Correct Answer)
C. Hypertension
D. Diabetes mellitus
Rationale:
Ig therapy is primarily used to treat patients with antibody deficiencies and certain autoimmune
conditions.
3. Which immunoglobulin class is MOST abundant in human serum?
A. IgA
B. IgE
C. IgG (Correct Answer)
D. IgM
Rationale:
IgG constitutes approximately 75% of total serum immunoglobulins and provides long-term
immunity.
,4. A patient receiving IVIG develops headache, fever, and chills during infusion.
The MOST appropriate initial action is to:
A. Discontinue therapy permanently
B. Increase infusion rate
C. Slow or temporarily stop the infusion (Correct Answer)
D. Administer antibiotics
Rationale:
Infusion-related reactions are common and usually managed by slowing or pausing the infusion.
5. Which route of administration is commonly associated with fewer systemic
adverse effects?
A. Intravenous
B. Intramuscular
C. Subcutaneous (Correct Answer)
D. Oral
Rationale:
Subcutaneous immunoglobulin (SCIG) has a lower risk of systemic reactions compared to IVIG.
6. The PRIMARY purpose of Ig product lot tracking is to:
A. Control inventory costs
B. Improve pharmacy workflow
C. Ensure patient safety and traceability (Correct Answer)
D. Increase reimbursement
Rationale:
Lot tracking enables recall management and patient safety monitoring.
7. Which adverse effect is MOST associated with rapid IVIG infusion?
A. Hypoglycemia
B. Aseptic meningitis (Correct Answer)
C. Liver failure
D. QT prolongation
,Rationale:
Rapid infusion rates increase the risk of aseptic meningitis and severe headaches.
8. Renal dysfunction risk with IVIG is MOST associated with products
containing:
A. Albumin
B. Maltose
C. Sucrose (Correct Answer)
D. Sodium chloride
Rationale:
Sucrose-containing IVIG products have been linked to osmotic nephrosis.
9. Prior to initiating Ig therapy, pharmacists should verify:
A. Insurance approval only
B. Patient age
C. Indication, dose, and patient-specific risk factors (Correct Answer)
D. Infusion room availability
Rationale:
Clinical appropriateness and patient safety checks are essential before initiation.
10. Which patient population requires the MOST cautious use of IVIG?
A. Adolescents
B. Athletes
C. Patients with renal impairment (Correct Answer)
D. Patients with seasonal allergies
Rationale:
Renal impairment increases the risk of IVIG-associated nephrotoxicity.
11. The standard dosing of IVIG is typically based on:
, A. Height
B. Age
C. Body weight (Correct Answer)
D. Body mass index
Rationale:
IVIG dosing is weight-based to ensure therapeutic effectiveness.
12. Which laboratory value is MOST important to monitor during long-term Ig
therapy?
A. Hemoglobin A1c
B. Potassium
C. Serum IgG trough levels (Correct Answer)
D. Platelet count
Rationale:
Trough IgG levels help guide dosing adjustments and effectiveness.
13. A patient receiving SCIG reports mild redness and swelling at the injection
site. This reaction is BEST classified as:
A. Severe systemic reaction
B. Allergic anaphylaxis
C. Expected local reaction (Correct Answer)
D. Medication error
Rationale:
Local site reactions are common and usually self-limiting with SCIG.
14. Which condition is an FDA-approved indication for IVIG?
A. Osteoarthritis
B. Immune thrombocytopenia (Correct Answer)
C. Asthma
D. Hyperlipidemia
Rationale:
IVIG is FDA-approved for immune thrombocytopenia (ITP).
2026
1. The PRIMARY role of an Ig Certified Pharmacist is to:
A. Dispense only intravenous medications
B. Ensure safe, effective, and compliant use of immunoglobulin therapy (Correct Answer)
C. Replace prescriber decision-making
D. Manage hospital staffing schedules
Rationale:
IgCP pharmacists specialize in optimizing immunoglobulin (Ig) therapy, ensuring
appropriateness, safety, and regulatory compliance.
2. Immunoglobulin therapy is MOST commonly indicated for:
A. Acute bacterial infections
B. Primary immunodeficiency disorders (Correct Answer)
C. Hypertension
D. Diabetes mellitus
Rationale:
Ig therapy is primarily used to treat patients with antibody deficiencies and certain autoimmune
conditions.
3. Which immunoglobulin class is MOST abundant in human serum?
A. IgA
B. IgE
C. IgG (Correct Answer)
D. IgM
Rationale:
IgG constitutes approximately 75% of total serum immunoglobulins and provides long-term
immunity.
,4. A patient receiving IVIG develops headache, fever, and chills during infusion.
The MOST appropriate initial action is to:
A. Discontinue therapy permanently
B. Increase infusion rate
C. Slow or temporarily stop the infusion (Correct Answer)
D. Administer antibiotics
Rationale:
Infusion-related reactions are common and usually managed by slowing or pausing the infusion.
5. Which route of administration is commonly associated with fewer systemic
adverse effects?
A. Intravenous
B. Intramuscular
C. Subcutaneous (Correct Answer)
D. Oral
Rationale:
Subcutaneous immunoglobulin (SCIG) has a lower risk of systemic reactions compared to IVIG.
6. The PRIMARY purpose of Ig product lot tracking is to:
A. Control inventory costs
B. Improve pharmacy workflow
C. Ensure patient safety and traceability (Correct Answer)
D. Increase reimbursement
Rationale:
Lot tracking enables recall management and patient safety monitoring.
7. Which adverse effect is MOST associated with rapid IVIG infusion?
A. Hypoglycemia
B. Aseptic meningitis (Correct Answer)
C. Liver failure
D. QT prolongation
,Rationale:
Rapid infusion rates increase the risk of aseptic meningitis and severe headaches.
8. Renal dysfunction risk with IVIG is MOST associated with products
containing:
A. Albumin
B. Maltose
C. Sucrose (Correct Answer)
D. Sodium chloride
Rationale:
Sucrose-containing IVIG products have been linked to osmotic nephrosis.
9. Prior to initiating Ig therapy, pharmacists should verify:
A. Insurance approval only
B. Patient age
C. Indication, dose, and patient-specific risk factors (Correct Answer)
D. Infusion room availability
Rationale:
Clinical appropriateness and patient safety checks are essential before initiation.
10. Which patient population requires the MOST cautious use of IVIG?
A. Adolescents
B. Athletes
C. Patients with renal impairment (Correct Answer)
D. Patients with seasonal allergies
Rationale:
Renal impairment increases the risk of IVIG-associated nephrotoxicity.
11. The standard dosing of IVIG is typically based on:
, A. Height
B. Age
C. Body weight (Correct Answer)
D. Body mass index
Rationale:
IVIG dosing is weight-based to ensure therapeutic effectiveness.
12. Which laboratory value is MOST important to monitor during long-term Ig
therapy?
A. Hemoglobin A1c
B. Potassium
C. Serum IgG trough levels (Correct Answer)
D. Platelet count
Rationale:
Trough IgG levels help guide dosing adjustments and effectiveness.
13. A patient receiving SCIG reports mild redness and swelling at the injection
site. This reaction is BEST classified as:
A. Severe systemic reaction
B. Allergic anaphylaxis
C. Expected local reaction (Correct Answer)
D. Medication error
Rationale:
Local site reactions are common and usually self-limiting with SCIG.
14. Which condition is an FDA-approved indication for IVIG?
A. Osteoarthritis
B. Immune thrombocytopenia (Correct Answer)
C. Asthma
D. Hyperlipidemia
Rationale:
IVIG is FDA-approved for immune thrombocytopenia (ITP).
